Market News

Manufacturers Life Insurance Company The Has Lowered Its Affiliated Managers Group (AMG) Position; Corindus Vascular Robotics (de) (NYSEAMERICAN:CVRS) Shorts Up By 0.1%

Manufacturers Life Insurance Company The decreased Affiliated Managers Group (AMG) stake by 6.45% reported in 2017Q3 SEC filing. Manufacturers Life Insurance Company The sold 231,640 shares as Affiliated Managers Group (AMG)’s stock declined 9.34%. The Manufacturers Life Insurance Company The holds 3.36 million shares with $637.78 million value, down from 3.59 million last quarter. Affiliated Managers Group now has $10.60 billion valuation. The stock increased 1.85% or $3.46 during the last trading session, reaching $190.76. About 326,526 shares traded. Affiliated Managers Group, Inc. (NYSE:AMG) has declined 5.60% since February 21, 2017 and is downtrending. It has underperformed by 22.30% the S&P500.

Corindus Vascular Robotics Inc (de) (NYSEAMERICAN:CVRS) had an increase of 0.1% in short interest. CVRS’s SI was 11.93 million shares in February as released by FINRA. Its up 0.1% from 11.92 million shares previously. With 767,200 avg volume, 16 days are for Corindus Vascular Robotics Inc (de) (NYSEAMERICAN:CVRS)’s short sellers to cover CVRS’s short positions. The SI to Corindus Vascular Robotics Inc (de)’s float is 11.76%. The stock decreased 3.48% or $0.04 during the last trading session, reaching $1.11. About 801,119 shares traded or 15.55% up from the average. Corindus Vascular Robotics, Inc. (NYSEAMERICAN:CVRS) has risen 8.65% since February 21, 2017 and is uptrending. It has underperformed by 8.05% the S&P500.

Corindus Vascular Robotics, Inc. designs, makes, and sells robotic-assisted precision vascular intervention systems for use in interventional vascular procedures. The company has market cap of $209.46 million. The firm offers CorPath system, a medical device with robotic-assisted precision for radial, coronary, and peripheral procedures. It currently has negative earnings. The Company’s CorPath system facilitates stent positioning for PCI procedures by allowing a physician to measure, manipulate, and advance devices with robotic precision; and CorPath GRX system enables the precise, robotic-assisted control of coronary guide catheters, guidewires, and balloon/stent devices from the safety of a radiation-shielded interventional cockpit.

Analysts await Affiliated Managers Group, Inc. (NYSE:AMG) to report earnings on May, 7. They expect $3.92 earnings per share, up 22.12% or $0.71 from last year’s $3.21 per share. AMG’s profit will be $217.89M for 12.17 P/E if the $3.92 EPS becomes a reality. After $4.68 actual earnings per share reported by Affiliated Managers Group, Inc. for the previous quarter, Wall Street now forecasts -16.24% negative EPS growth.

Among 10 analysts covering Affiliated Managers Group (NYSE:AMG), 8 have Buy rating, 0 Sell and 2 Hold. Therefore 80% are positive. Affiliated Managers Group had 48 analyst reports since August 9, 2015 according to SRatingsIntel. On Tuesday, October 10 the stock rating was maintained by Jefferies with “Buy”. Wood maintained the stock with “Outperform” rating in Tuesday, August 2 report. The company was downgraded on Wednesday, January 3 by Credit Suisse. The stock has “Buy” rating by Citigroup on Tuesday, January 30. The stock has “Hold” rating by Deutsche Bank on Friday, November 4. The firm has “Buy” rating by Jefferies given on Monday, July 11. The firm has “Buy” rating given on Thursday, December 21 by Keefe Bruyette & Woods. The company was maintained on Tuesday, January 26 by Deutsche Bank. The rating was downgraded by Citigroup to “Neutral” on Tuesday, December 15. The stock has “Buy” rating by Barrington on Wednesday, October 4.

Leave a Reply

Your email address will not be published. Required fields are marked *